Fighting cancer with a Patient's own supercharged immune cells
NCT ID NCT07444437
Summary
This study is testing a new personalized treatment called LM103 TILs to see if it can help prevent lung cancer from coming back after surgery. It is for people with a specific type of non-small cell lung cancer who have already had initial treatment. Researchers will take a patient's own immune cells from their tumor, grow more of them in a lab, and then infuse them back into the patient to try to keep the cancer away.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Henan Provincial People's Hospital
Zhengzhou, Henan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.